Area of research
Radiology, Nuclear Medicine and Imaging · Otorhinolaryngology
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Head and Neck Cancer Studies, and Lung Cancer Diagnosis and Treatment.
ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies.
ACR-ACNM-ARS-SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride.
ACR-ACNM-ARS-SNMMI-SPR Practice Parameter for Treatment of Benign and Malignant Thyroid Disease With I-131 Sodium Iodide.
ACR–ABS–ACNM–ARS–SIR–SNMMI Practice Parameter for Radioembolization of Liver Malignancies
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163.
Summary: Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT for Initial Staging of Malignant Disease.
Trends in Investigations for Suspected Head and Neck Carcinoma of the Unknown Primary: A HNCIG and IFHNOS International Survey of Practice.
Supplementary Table1 from Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
Supplementary Materials1 from Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
Data from Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients
Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations
Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.
Quarter-Century PET/CT Transformation of Oncology: Lymphoma.
Quarter-Century PET/Computed Tomography Transformation of Oncology: Hepatobiliary and Pancreatic Cancer.
Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685.
Role of PET/Computed Tomography in Gastric and Colorectal Malignancies.
Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.
ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals.
Quarter Century Positron Emission Tomography/Computed Tomography Transformation of Oncology: Head and Neck Cancer.
Quarter Century Clinical PET/Computed Tomography: Transforming Medical Oncology Practice.
Quarter Century PET/Computed Tomography Transformation of Oncology: Neuroendocrine Tumors.
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.
Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.
Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis.
ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer
ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer.
Gastroenteropancreatic Neuroendocrine Tumor Diagnosis: DOTATATE PET/CT.
Neuroendocrine Neoplasms: Epidemiology, Diagnosis, and Management.